1 Min Read
Dec 7 (Reuters) - Cancer Genetics Inc :
* Cancer Genetics, Inc is selected by BeiGene, Ltd to collaborate on clinical trial services & advance portfolio of Novel Oncology Therapeutics Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.